Senior Managing Consultant Radiation Oncology | Clinician Scientist @Uniklinik_Fr. Passionate about #GU cancers + imaging. Views are my own. @ESTRO_RT @degro_ev
Freiburg im Breisgau
Joined October 2010
- Tweets155
- Following561
- Followers507
- Likes740
Simon Spohn retweeted
Excited to be at #ESTRO2026 in Stockholm 🇸🇪 — 11 team members, 14 contributions from the Department of Radiation Oncology University Medical Center Freiburg.
Let’s go! 🎉
#RadiationOncology
@ESTRO_RT
Excited to share our new paper on intrafractional fiducial-based image guidance for focal dose-escalated SBRT in PCa now in PHIRO. This approach easily boosts precision & efficacy for linac-based SBRT in prostate cancer!
Check full paper here: sciencedirect.com/science/ar…
@ESTRO_RT
Simon Spohn retweeted
Check out our comment on the WOLVERINE meta analysis just published in @TheLancetOncol !
MDT in prostate cancer is here to stay!
@Simon_Spohn @AncaGrosu1
thelancet.com/journals/lanon…
So proud of residents @SLBuerkle & Philipp Waibel for presenting at #EMUC25 in Prague 🙌 Their fantastic work earned a Highly Rated Abstract ribbon👌🏻! Great to see them representing our centre from Freiburg & Radiation Oncology with enthusiasm and quality.
Join us for this years #EMUC25 falcon workshop 🙌
Coming to #EMUC25 ? Don’t miss the chance to sign up for the FALCON prostate contouring course @estro with superstar faculty @PaulSargos @Simon_Spohn and Thomas Zilli emuc.org/scientific-programm…
Honored to join “Rising Stars in Oncology” at the Federal Ministry in Berlin 🇩🇪 representing UKF & Radiation Oncology. Minister Bär highlighted the need to strengthen top-level cancer research in Germany. 💡 #Oncology #CancerResearch #Networking
Great to be part of the annual German/Swiss/Austrian Oncology Congress #DGHO25 in Cologne 🇩🇪 — sharing insights on SBRT in oligometastatic #ProstateCancer.
Inspiring discussions showing how multidisciplinary collaboration continues to shape the future of cancer care! 💡💬
Leopoldina Symposium: AI & tech in medicine in the Focus. 🇩🇪 Debating Germany’s role as a research hub, regulatory updates & fostering innovation. Cross-sector exchange between medicine, science, industry & policy to drive future-ready clinical research. @Leopoldina @AncaGrosu1
Simon Spohn retweeted
1st POSITIVE RCT in the #ASTRO2025 Plenary today! #BART meets primary EP of LRFS in High risk MIBC!!!
Simon Spohn retweeted
This is big news 👇 No benefit to prophylactic nodal irradiation in NRG/RTOG 0924
#astro25
@NRGonc Rtog 0924 trial on 2500 patients testing whole pelvic RT.
Negative trial
-OS no difference
-PCSM no difference
-DM no difference
-BCR was not SS different with only 4% difference at 10 years.
-toxicity increased
3 cooperative group trials now negative: getug01, Rtog 9413, Rtog 0924.
Goodbye WPRT
Simon Spohn retweeted
📣 Last call for #EMUC25 abstracts! 👉Are you ready to showcase your #UrologicalCancer research to help enhance the quality of uro-oncological care?
📅Submit by 1 August, 2025
See topic list & submission details here 👇
emuc.org/scientific-programm…
@myESMO @ESTRO_RT
Simon Spohn retweeted
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
sciencedirect.com/science/ar…
This systematic review and meta-analysis by the DADSPORT Collaboration evaluated the impact of hormone therapy (HT) added to postoperative radiotherapy (RT) in nonmetastatic #ProstateCancer across five randomized controlled trials involving 4,411 participants. While HT did not significantly improve overall survival (OS) in the general population, it did show meaningful benefits in metastasis-free survival (MFS) and prostate cancer–specific survival (PCSS), each with a 4% absolute improvement at 8 years.
Notably, OS benefits may be limited to patients with higher pre-RT PSA levels or CAPRA-S scores.
These findings support the use of adjuvant HT to improve cancer outcomes, particularly in higher-risk patients.
@DrSpratticus
@AmarUKishan
@drjefstathiou
@PCaParker
@_APollack
@PaulSargos
@felixfengmd
@OncoAlert
@Silke_Gillessen @AOmlin
@nataliagandur @bavilima
Simon Spohn retweeted
Great to see many enthusiastic colleagues at our Co-IMPACT meeting. Thanks to all for coming and bringing this huge project forward! #ESTRO2025
Simon Spohn retweeted
@ESTRO_RT Voting is open!!! Would be happy to get your support. See you all in Vienna.
✨ ESTRO Board Elections 2025: Meet Piet Ost, candidate for the Clinical seat at ESTRO. 🗳
👉 Get to know his vision and goals in this short interview: bit.ly/4c16yIf
#ESTROElections
Simon Spohn retweeted
Hot of the press @IJROBP: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial
Full text here: doi.org/10.1016/j.ijrobp.202…
Simon Spohn retweeted
Excited to run for a position in the ESTRO board. Be sure to vote. @ZilliThomas @PaulSargos @VedangMurthy @alison_tree @achoud72 @stephane_supiot @Mat_Guc and all others
ESTRO 2025 Board Elections: Meet the Candidates!
The Board elections are approaching: Two candidates are running for the Physics seats & two for the Clinical seats.
🗳️ Election period: 20 March–20 April
👥 Who can vote? Full ESTRO members (2024 & 2025)
👉shorturl.at/bXRrc
Simon Spohn retweeted
Today, the @Uniklinik_Fr and @VarianMedSys proudly hosted the official groundbreaking for the new Technology Innovation Lab 🙌🙌
This unique collaboration between academia and industry will pave the way for transformative breakthroughs in #cancer care
#HealthcareInnovation #TIL
Last day of #EMUC24 is packed with highlights. Excellent talks by leaders of the field @AttardLab @alison_tree @Ecastromarcos and Wolfgang Fendler!
Special lecture by Ajay Aggarwal on the role of politics in cancer care ☀️
@ESTRO_RT @Uroweb @myESMO
